MARKET

BIXT

BIXT

Bioxytran Inc
OTCMQB
0.020
-0.001
-4.25%
Closed 13:09 09/08 EDT
OPEN
0.020
PREV CLOSE
0.021
HIGH
0.020
LOW
0.020
VOLUME
50.00K
TURNOVER
1.02K
52 WEEK HIGH
0.090
52 WEEK LOW
0.020
MARKET CAP
2.33M
P/E (TTM)
-0.6304
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BIXT last week (0831-0904)?
Weekly Report · 2d ago
Weekly Report: what happened at BIXT last week (0824-0828)?
Weekly Report · 08/31 09:49
Weekly Report: what happened at BIXT last week (0817-0821)?
Weekly Report · 08/24 09:50
Weekly Report: what happened at BIXT last week (0810-0814)?
Weekly Report · 08/17 09:50
Based on the provided financial report articles, I generated the title for the article: "Quarterly Financial Report for Q2 2026: [Company Name] Reports [Financial Results]" Please note that the actual title may vary depending on the specific financial report and the company's reporting style.
Press release · 08/15 08:02
Bioxytran reports initial clinical observations from PLICID trial
TipRanks · 08/11 11:34
Weekly Report: what happened at BIXT last week (0803-0807)?
Weekly Report · 08/10 09:47
Weekly Report: what happened at BIXT last week (0727-0731)?
Weekly Report · 08/03 09:47
More
About BIXT
Bioxytran, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans. The Company's lead drug candidate, code named BXT-25, is an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer with intended applications, which includes the treatment of hypoxic conditions in the brain resulting from stroke. The Company, through its subsidiary, Pharmalectin Inc., is focused on the development, manufacturing, and commercialization of therapeutic drugs designed to address viral diseases in humans. Pharmalectin Inc. has developed a method designed to reduce the viral load and modulate the immune system using a galectin inhibitor. Its lead drug candidate, named ProLectin-Rx, is a complex polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin.

Webull offers Bioxytran Inc stock information, including OTCMQB: BIXT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIXT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIXT stock methods without spending real money on the virtual paper trading platform.